Blepharospasm
📧 Sign up to get email alerts when something new happens for Blepharospasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm [Phase 3]
Phase 3 trial comparing incobotulinumtoxinA (Xeomin) to placebo in blepharospasm; results were posted in 2010.
-
FDA approval · 2010-07-30FDA Approved: XEOMIN — Original Application (Merz Pharmaceuticals, LLC)
FDA approved Xeomin (incobotulinumtoxinA) from Merz Pharmaceuticals in an original Biologics License Application. It established initial ind…
-
CLINICAL_TRIALS trial_result · 2009-07-09Clinical Trial Update: Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm [Phase 4]
This Phase 4 clinical trial compares two botulinum toxin type A products for the treatment of blepharospasm; results were posted in 2009.
-
CLINICAL_TRIALS trial_result · 2008-05-22Clinical Trial Update: Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm [Phase 3]
A Phase 3 trial comparing a Korean botulinum toxin type A formulation to Botox for essential blepharospasm has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Mexiletine for the Treatment of Focal Dystonia [Phase 2]
A Phase 2 trial evaluating mexiletine for focal dystonia, including blepharospasm, has completed. The update summarizes the trial's efficacy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.